Nanotechnology Now

Our NanoNews Digest Sponsors
Heifer International



Home > Press > Nanogen Announces Collaboration with Canadian Agencies to Develop Veterinary and Bioterror Diagnostics

Abstract:
Nanogen, Inc. (Nasdaq:NGEN), developer of advanced diagnostic products, announced today that it has received project funding from several Canadian agencies, including the Canadian Food Inspection Agency (CFIA). The purpose of the funding and collaborative agreement is to develop diagnostic tools for the detection of natural or potential bioterror threats to livestock, such as foot and mouth disease and avian flu, employing the company's NanoChip® platform.

Nanogen Announces Collaboration with Canadian Agencies to Develop Veterinary and Bioterror Diagnostics

SAN DIEGO, CA | Posted on June 12th, 2007

"Although the majority of our NanoChip® instruments are used in basic research and human clinical diagnostics applications, we have always known that the platform's flexibility confers benefit in other markets, such as veterinary diagnostics and the monitoring of bioterror threats," said Nanogen president and chief operating officer David Ludvigson.

Foot and mouth disease, a viral infection that devastated the beef industry in the United Kingdom in 2001, is a bioterror concern because it is easily transmissible from animal to animal. Economic losses could be enormous - the 2001 epidemic cost an estimated $12 billion, according to a study sponsored by the Wash., D.C.-based Center for Strategic and International Studies. Avian flu poses a similar threat to poultry stocks.

The NanoChip® 400 is the company's second generation automated multiplexing platform, which uses advanced microarray technology for performing pathogen sequence detection and genotyping applications. Multiple samples with multiple targets can be applied to an open and flexible electronic microarray, the NanoChip cartridge, which may be reused until all test sites have been utilized. As the NanoChip arrays are built by users rather than containing pre-determined content, the system provides a simple, fast and cost effective means for performing molecular testing.

The project, titled "Adaptation of Recently Developed DNA Microarrays to NanoChip Microarray Technology for Detection of Agroterrorism Agents" was approved by Defence Research and Development Canada through the CRTI Program (CBRNE [Chemical, Biological, Radiological, and Nuclear] Research and Technology Initiative (CRTI). Financial terms were not disclosed. Additional collaborators include the CFIA's laboratory in Lethbridge, Alberta and the National Center for Foreign Animal Diseases located in Winnipeg, Manitoba.

####

About Nanogen, Inc.
Nanogen's advanced technologies provide researchers, clinicians and physicians worldwide with improved methods and tools to predict, diagnose, and ultimately help treat disease. The company's products include real-time PCR reagents, the NanoChip® electronic microarray platform and a line of rapid diagnostic tests. Nanogen's ten years of pioneering research involving nanotechnology holds the promise of miniaturization and continues to be supported for its potential for diagnostic and biodefense applications. For additional information please visit Nanogen's website at http://www.nanogen.com .

Forward-Looking Statement

This press release contains forward-looking statements that are subject to risks and uncertainties that could cause actual results to differ materially from those set forth in the forward-looking statements, including whether patents owned or licensed by Nanogen will be developed into products, whether the patents owned by Nanogen offer any protection against competitors with competing technologies, whether products under development can be successfully developed and commercialized, whether results reported by our customers or partners can be identically replicated, and other risks and uncertainties discussed under the caption "Factors That May Affect Results" and elsewhere in Nanogen’s Form 10-K or Form 10-Q most recently filed with the Securities and Exchange Commission. These forward-looking statements speak only as of the date hereof. Nanogen disclaims any intent or obligation to update these forward-looking statements.

For more information, please click here

Contacts:
Nanogen, Inc.
Robert Saltmarsh, Chief Financial Officer, 858-410-4600
or
Suzanne Clancy, Corporate Communications, 858-410-4688

Copyright © Business Wire 2007

If you have a comment, please Contact us.

Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.

Bookmark:
Delicious Digg Newsvine Google Yahoo Reddit Magnoliacom Furl Facebook

Related News Press

Announcements

What heat can tell us about battery chemistry: using the Peltier effect to study lithium-ion cells March 8th, 2024

Curcumin nanoemulsion is tested for treatment of intestinal inflammation: A formulation developed by Brazilian researchers proved effective in tests involving mice March 8th, 2024

The Access to Advanced Health Institute receives up to $12.7 million to develop novel nanoalum adjuvant formulation for better protection against tuberculosis and pandemic influenza March 8th, 2024

Nanoscale CL thermometry with lanthanide-doped heavy-metal oxide in TEM March 8th, 2024

Homeland Security

The picture of health: Virginia Tech researchers enhance bioimaging and sensing with quantum photonics June 30th, 2023

Sensors developed at URI can identify threats at the molecular level: More sensitive than a dog's nose and the sensors don't get tired May 21st, 2021

UCF researchers generate attosecond light from industrial laser: The ultrafast measurement of the motion of electrons inside atoms, molecules and solids at their natural time scale is known as attosecond science and could have important implications in power generation, chemical- August 25th, 2020

Highly sensitive dopamine detector uses 2D materials August 7th, 2020

Food/Agriculture/Supplements

$900,000 awarded to optimize graphene energy harvesting devices: The WoodNext Foundation's commitment to U of A physicist Paul Thibado will be used to develop sensor systems compatible with six different power sources January 12th, 2024

Silver nanoparticles: guaranteeing antimicrobial safe-tea November 17th, 2023

Night-time radiative warming using the atmosphere November 17th, 2023

DGIST and New Life Group launched a research project on "Functional beauty and health products using the latest nanotechnology" May 12th, 2023

Alliances/Trade associations/Partnerships/Distributorships

Manchester graphene spin-out signs $1billion game-changing deal to help tackle global sustainability challenges: Landmark deal for the commercialisation of graphene April 14th, 2023

Chicago Quantum Exchange welcomes six new partners highlighting quantum technology solutions, from Chicago and beyond September 23rd, 2022

CEA & Partners Present ‘Powerful Step Towards Industrialization’ Of Linear Si Quantum Dot Arrays Using FDSOI Material at VLSI Symposium: Invited paper reports 3-step characterization chain and resulting methodologies and metrics that accelerate learning, provide data on device pe June 17th, 2022

University of Illinois Chicago joins Brookhaven Lab's Quantum Center June 10th, 2022

NanoNews-Digest
The latest news from around the world, FREE




  Premium Products
NanoNews-Custom
Only the news you want to read!
 Learn More
NanoStrategies
Full-service, expert consulting
 Learn More











ASP
Nanotechnology Now Featured Books




NNN

The Hunger Project